The Impact of Improved Vagal Function on Periaqueductal Gray Connectivity
A legfontosabb adatok
- Hol
- Richmond (Egyesült Államok)A helyszín megnézése
Neked szólhat?
Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.
- 18 és 50 év között vagy?
Forrás: NCT05618067: ki vehet részt
Helyszínek itt: Egyesült Államok
- Virnigia Commonwealth UniversityRichmond, Egyesült ÁllamokContact: Thomas Chelimsky, M.D.No longer taking part
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakA vizsgálat adatai
- Ki végzi
- Virginia Commonwealth University
- Azonosító
- NCT05618067
- A regiszteradat frissítve
- 2026. szeptember 16.
- Eredeti leírás
This study is being to see if participating in breathing exercise training and practicing this training will help with Postural tachycardia syndrome (POTS). The information may help doctors to learn more about how the different parts of people's brains communicate.A teljes eredeti leírásKevesebb
This study is being to see if participating in breathing exercise training and practicing this training will help with Postural tachycardia syndrome (POTS). The information may help doctors to learn more about how the different parts of people's brains communicate.
Bevonási feltételek: Age 18-50 years; Diagnosis of POTS, orthostatic intolerance (with or without syncope), syncope, or near-syncope; Can speak and read in English; Upcoming new patient VCU Comprehensive Autonomics Center clinic visit scheduled at least 1 week in the future.
Kizáró feltételek: Treatment with a drug or medical device within the previous 30 days that has not received regulatory approval; Any major surgical intervention with general anesthesia in the last 60 days and minor procedure, such as tooth extraction, endoscopy, etc., with local or conscious sedation within 7 days; Inflammatory arthritis, connective tissue or auto-immune disorder; Any chronic neurological disorder besides POTS, orthostatic intolerance (with or without syncope), syncope, or near-syncope; Neuropathy, central nervous system disorder (e.g., Cerebral palsy, developmental delay, seizure disorder, MS, stroke, etc.); Any condition that in the judgment of the investigator would interfere with the patient's ability to provide informed consent, comply with study instructions, place the patient at increased risk, or which would clearly confound the interpretation of the study results (specific reason will be documented); Evidence of unstable medical disorder, such as kidney (rising creatinine, or end-stage renal failure) or liver impairment (rising AST or ALT, or end-stage with coagulopathy), poorly controlled significant cardiovascular (CHF), respiratory, endocrine (diabetes - A1c > 9 - or untreated thyroid dysfunction) or uncontrolled psychiatric illness (such as untreated depression, psychosis, etc.); Patients who have already had a new patient clinic visit where they were exposed to breathing exercise education; Use of hormones (except insulin, thyroid replacement or oral contraceptives, which will be carefully documented); Current substance or alcohol abuse; Any on-going or pending medical, health or disability related litigation, or current pursuit of disability; Chronic use of narcotics for pain; Claustrophobia or any metal hardware that may interfere with MRI; Investigators and study staff.